Are you Dr. Civin?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 47 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
600 N Wolfe St
Baltimore, MD 21287Phone+1 410-955-8751- Is this information wrong?
Summary
- Dr. Curt Civin, MD is an oncologist in Baltimore, Maryland. He is currently licensed to practice medicine in Maryland. He is a Professor at University of Maryland School of Medicine.
Education & Training
- Children's Hospital/Boston Medical CenterResidency, Pediatrics, 1974 - 1976
- Harvard Medical SchoolClass of 1974
Certifications & Licensure
- MD State Medical License 1976 - 2022
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1992
- Super Doctor SuperDoctors.com
Publications & Presentations
PubMed
- ART714 is a best-in-class antileukemic 2-carbon-linked dimeric artemisinin derivative.Amanda B Kagan, Blake S Moses, Rena Lapidus, Bryan T Mott, Ganesha Rai, Nicole M Anders, Stephen W Hoag, Michelle A Rudek, Curt I Civin> ;Cancer Chemotherapy and Pharmacology. 2023 Jul 1
- 3 citationsComparative efficacy and mechanism of action of cardiac progenitor cells after cardiac injury.Muthukumar Gunasekaran, Rachana Mishra, Progyaparamita Saha, David Morales, Wen-Chih Cheng, Arun R Jayaraman, Jessica R Hoffman, Lauran Davidson, Ling Chen, Aakash M S...> ;Iscience. 2022 Aug 19
- 2 citationsHypoxia-inducible factor 1-alpha enhances the secretome to rejuvenate adult cardiosphere-derived cells.Progyaparamita Saha, MinJung Kim, Antariksh Tulshyan, Yin Guo, Rachana Mishra, Deqiang Li, Curt I. Civin, Sunjay Kaushal, Sudhish Sharma> ;The Journal of Thoracic and Cardiovascular Surgery. 2021 Jul 17
- Join now to see all
Press Mentions
- Academic Labs Are Opening Back up. Still, Research Isn’t Exactly Back to NormalJuly 20th, 2020
- CITI Program, in Collaboration with Consortium, Launches Free Online Course “COVID-19: Back to Campus”June 16th, 2020
- New Anti-IL-7Rα Monoclonal Antibodies Show Efficacy Against T Cell Acute Lymphoblastic Leukemia in Pre-Clinical ModelsAugust 22nd, 2019
- Join now to see all